FDA Adverse Event Death Summary report: N

HEMOCHRON MICROCOAGULATION SYSTEM

MDR report key: 1313086 · Received February 10, 2009

Report

Report Number
2248721-2009-00044
Event Type
Death
Date Received
February 10, 2009
Date of Event
September 24, 2008
Report Date
February 10, 2009
Manufacturer
INTERNATIONAL TECHNIDYNE CORPORATION
Product Code
JBP
PMA / PMN Number
K960749
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

MDR FILING DUE TO RECENT RECEIPT OF INFORMATION BY ITC CLARIFYING REPORTING RULES WHERE BOTH MULTIPLE PATIENTS AND MULTIPLE DEVICES ARE INVOLVED. DUE TO THIS, MDR'S 2248721-2008-00018 AND 2248721-2008-00019 HAVE BEEN PREVIOUSLY FILED RELATED TO SAME REPORTED ADVERSE EVENTS. CUSTOMER REPORTS HEMOCHRON SIGNATURE ELITE, BUT IS UNABLE TO SPECIFICALLY IDENTIFY WHICH INSTRUMENT(S) ARE INVOLVED IN EACH SPECIFIC ADVERSE EVENT. IN 2008, INTERNATIONAL TECHNIDYNE CORPORATION PERFORMED AN ON SITE INVESTIGATION OF THE DEVICE ALLEGED TO BE INVOLVED. THE FOLLOWING EVALUATIONS WERE PERFORMED: PHYSICAL DAMAGE, HEPARIN RESPONSE, PRECISION, DATA DOWNLOAD FROM DEVICE MEMORY. THE RESULTS OF THE ABOVE EVALUATIONS CONCLUDED THAT THE DEVICE IS, AND WAS OPERATING IN ACCORDANCE WITH MANUFACTURING SPECIFICATIONS, AND THAT THE FACILITY CONTINUES TO USE THE DEVICE WITHOUT FURTHER REPORTS OF MALFUNCTIONS.

Description of Event or Problem · 1

CUSTOMER REPORTS 4 CRITICALLY ILL PEDIATRIC ECMO PATIENTS EXPIRED OVER AN UNSPECIFIED SIX WEEK PERIOD. DURING TREATMENT, CLOTTING TIME WAS MEASURED USING HEMOCHRON ACT-LR / SIGNATURE ELITE INSTRUMENTS. AS 2 SIGNATURE ELITE INSTRUMENTS ARE IN USE, CUSTOMER IS UNABLE TO IDENTIFY WHICH INSTRUMENT USED WITH SPECIFIC PATIENTS. CUSTOMER REVIEWING MEDICATION REGIMEN FOR CASUALITY. THIS REPORT IS FOR PATIENT 4 OF 4.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 HEMOCHRON MICROCOAGULATION SYSTEM ACT-LR ASSAY / SIGNATURE ELITE INSTRUMEMENT JBP INTERNATIONAL TECHNIDYNE CORPORATION SIGNATURE ELITE ACT-LR-UNAVAILABLE

Patients

Seq Age Sex Outcome Treatment
1 2 YR Death